LDLR and atherosclerosis: Given the absence of LDLR in Ldlr−/− mice, and therefore their inability to upregulate LDLR in response to low hepatic cholesterol levels or inflammation, further studies are necessary to investigate the development of atherosclerosis and cholesterolaemia in patients after allo-HCT and in mice with different genetic backgrounds.